跳至主要内容
临床试验/NCT04978948
NCT04978948招募中不适用

Study of STIM1 Membrane Expression During Autoimmune Diseases

University Hospital, Brest8 个研究点 分布在 1 个国家目标入组 670 人开始时间: 2021年5月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
670
试验地点
8
主要终点
level of STIM1-PM

研究概览

简要总结

The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM.

This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of one of the autoimmune diseases

排除标准

  • Treatment with rituximab in the previous 12 months

结局指标

主要结局

level of STIM1-PM

时间窗: Day 0

Membrane expression level of STIM1-PM on the surface of immune cells, measured by flow cytometry

次要结局

  • correlation between STIM1 expression and Clinical Score(Day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验